A new erythropoietin product offers advantages for treating anemia in dialysis patients with end-stage renal disease. This treatment provides benefits over traditional methods like transfusions and androgens.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: